REGENXBIO-Regenxbio (RGNX) Reports Q4 Loss, Lags Revenue Estimates

Regenxbio (RGNX) came out with a quarterly loss of $1.01 per share versus the Zacks Consensus Estimate of a loss of$ 1.27. This compares to loss of $1.43 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 20.47%. A quarter ago, it was expected that this biotechnology company would post a loss of$ 1.16 per share when it actually produced a loss of $1.17, delivering a surprise of -0.86%.Over the last four quarters, the company has ...